Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1982 3
1983 3
1984 2
1985 7
1986 8
1987 13
1988 7
1989 9
1990 7
1991 6
1992 11
1993 16
1994 9
1995 22
1996 12
1997 23
1998 20
1999 32
2000 34
2001 46
2002 49
2003 83
2004 102
2005 121
2006 98
2007 116
2008 124
2009 108
2010 164
2011 172
2012 234
2013 230
2014 264
2015 319
2016 340
2017 325
2018 401
2019 438
2020 522
2021 553
2022 694
2023 711
2024 759
2025 121

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6,629 results

Results by year

Filters applied: . Clear all
Page 1
Editorial: Anti-MDA5-Positive Dermatomyositis.
Gono T, Ye S, Han Q. Gono T, et al. Among authors: ye s. Front Med (Lausanne). 2022 May 31;9:941370. doi: 10.3389/fmed.2022.941370. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35712109 Free PMC article. No abstract available.
Reply.
Teng X, Liu Z, Wang H, Ye S. Teng X, et al. Among authors: ye s. Arthritis Rheumatol. 2016 Dec;68(12):3043. doi: 10.1002/art.39864. Arthritis Rheumatol. 2016. PMID: 27636588 No abstract available.
Thoracic Radiotherapy Improves the Survival in Patients With EGFR-Mutated Oligo-Organ Metastatic Non-Small Cell Lung Cancer Treated With Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors: A Multicenter, Randomized, Controlled, Phase III Trial.
Sun H, Li M, Huang W, Zhang J, Wei S, Yang Y, Wang Z, Ye S, Gong H, Zhang Y, Li J, Song H, Wang L, Chen X, Lin H, Ding G, Li H, Zheng A, Ma X, Chen S, Liu L, Zhang K, Fu C, Liu W, Wang J, Zhang X, Liu T, Han D, Zhao Q, Wu P, Yuan Q, Tian L, Zhang P, Wu X, Chen F, Zhang Z, Li B. Sun H, et al. Among authors: ye s. J Clin Oncol. 2025 Feb;43(4):412-421. doi: 10.1200/JCO.23.02075. Epub 2024 Oct 7. J Clin Oncol. 2025. PMID: 39374473 Clinical Trial.
Highly potent and broadly neutralizing anti-CD4 trimeric nanobodies inhibit HIV-1 infection by inducing CD4 conformational alteration.
Zhu L, Huang B, Wang X, Ni F, Ao M, Wang R, Zheng B, Chen C, Xue J, Zhu L, Yang C, Shi L, Geng S, Hu J, Yang M, Zhang D, Yang P, Li M, Li Y, Hu Q, Ye S, Zheng P, Wei H, Wu Z, Zhang L, Wang Y, Liu Y, Wu X. Zhu L, et al. Among authors: ye s. Nat Commun. 2024 Aug 13;15(1):6961. doi: 10.1038/s41467-024-51414-6. Nat Commun. 2024. PMID: 39138183 Free PMC article.
6,629 results